Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease

A crossover study

Joachim H. Ix, Cheryl A M Anderson, Gerard Smits, Martha S. Persky, Geoffrey A. Block

Research output: Contribution to journalArticle

Abstract

Background: Previous trials of binders in chronic kidney disease (CKD) stages 3-5 have shown only modest changes in serum phosphate but evaluated morning phosphate. It is unknown whether a circadian pattern of phosphate concentrations exists in CKD and is modifiable by dietary manipulation. Objectives: We determined the circadian pattern of serum phosphate concentrations in CKD and whether it was modifiable by altering absorbable phosphate. Design: This was a crossover feeding study in 11 CKD participants (estimated glomerular filtration rate: 30-45 mL · min-1 · 1.73 m-2) and 4 healthy control subjects. All subjects received high-phosphate (2500 mg/d), normal-phosphate (1500 mg/d), and low-phosphate (1000 mg/d plus 1000 mg lanthanum carbonate 3 times/d) diets for 5 d followed by a 10-d washout. After each 5-d feed, phosphate and other measurements were made every 4 h over 1 day. Results: In CKD participants who consumed the high-phosphate diet, there were circadian changes in phosphate with lowest concentrations (±SDs) at 0800 (4.2 ± 0.5 mg/dL) and 2 peaks at 1600 and 0400 (4.5 ± 0.8 and 4.4 ± 0.6 mg/dL, respectively), which were similar to those in healthy controls. Results with the normal-phosphate diet were similar. The low-phosphate diet altered the circadian rhythm (P = 0.02) such that 0400 and 1600 peaks were absent. Differences in phosphate for lowest- compared with highest-phosphate diets were smallest at 0800 and largest at 1600 (0.5 compared with 1.0 mg/dL) in CKD. Circadian changes in phosphate were not explained by urine phosphate excretion, parathyroid hormone, or fibroblast growth factor-23. Conclusions: A circadian pattern of serum phosphate is observed in CKD with lowest concentrations at 0800 and highest at 1600 and 0400. This circadian pattern is modifiable by phosphate intake and most evident at 1600. Future intervention studies targeting intestinal phosphate absorption should consider afternoon phosphate measurements.

Original languageEnglish (US)
Pages (from-to)1392-1397
Number of pages6
JournalAmerican Journal of Clinical Nutrition
Volume100
Issue number5
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Circadian Rhythm
Chronic Renal Insufficiency
Cross-Over Studies
Phosphates
Serum
Diet
Intestinal Absorption

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease : A crossover study. / Ix, Joachim H.; Anderson, Cheryl A M; Smits, Gerard; Persky, Martha S.; Block, Geoffrey A.

In: American Journal of Clinical Nutrition, Vol. 100, No. 5, 01.11.2014, p. 1392-1397.

Research output: Contribution to journalArticle

Ix, Joachim H. ; Anderson, Cheryl A M ; Smits, Gerard ; Persky, Martha S. ; Block, Geoffrey A. / Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease : A crossover study. In: American Journal of Clinical Nutrition. 2014 ; Vol. 100, No. 5. pp. 1392-1397.
@article{d6ce9b2d44384d80b9dde32cb129a18a,
title = "Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: A crossover study",
abstract = "Background: Previous trials of binders in chronic kidney disease (CKD) stages 3-5 have shown only modest changes in serum phosphate but evaluated morning phosphate. It is unknown whether a circadian pattern of phosphate concentrations exists in CKD and is modifiable by dietary manipulation. Objectives: We determined the circadian pattern of serum phosphate concentrations in CKD and whether it was modifiable by altering absorbable phosphate. Design: This was a crossover feeding study in 11 CKD participants (estimated glomerular filtration rate: 30-45 mL · min-1 · 1.73 m-2) and 4 healthy control subjects. All subjects received high-phosphate (2500 mg/d), normal-phosphate (1500 mg/d), and low-phosphate (1000 mg/d plus 1000 mg lanthanum carbonate 3 times/d) diets for 5 d followed by a 10-d washout. After each 5-d feed, phosphate and other measurements were made every 4 h over 1 day. Results: In CKD participants who consumed the high-phosphate diet, there were circadian changes in phosphate with lowest concentrations (±SDs) at 0800 (4.2 ± 0.5 mg/dL) and 2 peaks at 1600 and 0400 (4.5 ± 0.8 and 4.4 ± 0.6 mg/dL, respectively), which were similar to those in healthy controls. Results with the normal-phosphate diet were similar. The low-phosphate diet altered the circadian rhythm (P = 0.02) such that 0400 and 1600 peaks were absent. Differences in phosphate for lowest- compared with highest-phosphate diets were smallest at 0800 and largest at 1600 (0.5 compared with 1.0 mg/dL) in CKD. Circadian changes in phosphate were not explained by urine phosphate excretion, parathyroid hormone, or fibroblast growth factor-23. Conclusions: A circadian pattern of serum phosphate is observed in CKD with lowest concentrations at 0800 and highest at 1600 and 0400. This circadian pattern is modifiable by phosphate intake and most evident at 1600. Future intervention studies targeting intestinal phosphate absorption should consider afternoon phosphate measurements.",
author = "Ix, {Joachim H.} and Anderson, {Cheryl A M} and Gerard Smits and Persky, {Martha S.} and Block, {Geoffrey A.}",
year = "2014",
month = "11",
day = "1",
doi = "10.3945/ajcn.114.085498",
language = "English (US)",
volume = "100",
pages = "1392--1397",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "5",

}

TY - JOUR

T1 - Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease

T2 - A crossover study

AU - Ix, Joachim H.

AU - Anderson, Cheryl A M

AU - Smits, Gerard

AU - Persky, Martha S.

AU - Block, Geoffrey A.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Background: Previous trials of binders in chronic kidney disease (CKD) stages 3-5 have shown only modest changes in serum phosphate but evaluated morning phosphate. It is unknown whether a circadian pattern of phosphate concentrations exists in CKD and is modifiable by dietary manipulation. Objectives: We determined the circadian pattern of serum phosphate concentrations in CKD and whether it was modifiable by altering absorbable phosphate. Design: This was a crossover feeding study in 11 CKD participants (estimated glomerular filtration rate: 30-45 mL · min-1 · 1.73 m-2) and 4 healthy control subjects. All subjects received high-phosphate (2500 mg/d), normal-phosphate (1500 mg/d), and low-phosphate (1000 mg/d plus 1000 mg lanthanum carbonate 3 times/d) diets for 5 d followed by a 10-d washout. After each 5-d feed, phosphate and other measurements were made every 4 h over 1 day. Results: In CKD participants who consumed the high-phosphate diet, there were circadian changes in phosphate with lowest concentrations (±SDs) at 0800 (4.2 ± 0.5 mg/dL) and 2 peaks at 1600 and 0400 (4.5 ± 0.8 and 4.4 ± 0.6 mg/dL, respectively), which were similar to those in healthy controls. Results with the normal-phosphate diet were similar. The low-phosphate diet altered the circadian rhythm (P = 0.02) such that 0400 and 1600 peaks were absent. Differences in phosphate for lowest- compared with highest-phosphate diets were smallest at 0800 and largest at 1600 (0.5 compared with 1.0 mg/dL) in CKD. Circadian changes in phosphate were not explained by urine phosphate excretion, parathyroid hormone, or fibroblast growth factor-23. Conclusions: A circadian pattern of serum phosphate is observed in CKD with lowest concentrations at 0800 and highest at 1600 and 0400. This circadian pattern is modifiable by phosphate intake and most evident at 1600. Future intervention studies targeting intestinal phosphate absorption should consider afternoon phosphate measurements.

AB - Background: Previous trials of binders in chronic kidney disease (CKD) stages 3-5 have shown only modest changes in serum phosphate but evaluated morning phosphate. It is unknown whether a circadian pattern of phosphate concentrations exists in CKD and is modifiable by dietary manipulation. Objectives: We determined the circadian pattern of serum phosphate concentrations in CKD and whether it was modifiable by altering absorbable phosphate. Design: This was a crossover feeding study in 11 CKD participants (estimated glomerular filtration rate: 30-45 mL · min-1 · 1.73 m-2) and 4 healthy control subjects. All subjects received high-phosphate (2500 mg/d), normal-phosphate (1500 mg/d), and low-phosphate (1000 mg/d plus 1000 mg lanthanum carbonate 3 times/d) diets for 5 d followed by a 10-d washout. After each 5-d feed, phosphate and other measurements were made every 4 h over 1 day. Results: In CKD participants who consumed the high-phosphate diet, there were circadian changes in phosphate with lowest concentrations (±SDs) at 0800 (4.2 ± 0.5 mg/dL) and 2 peaks at 1600 and 0400 (4.5 ± 0.8 and 4.4 ± 0.6 mg/dL, respectively), which were similar to those in healthy controls. Results with the normal-phosphate diet were similar. The low-phosphate diet altered the circadian rhythm (P = 0.02) such that 0400 and 1600 peaks were absent. Differences in phosphate for lowest- compared with highest-phosphate diets were smallest at 0800 and largest at 1600 (0.5 compared with 1.0 mg/dL) in CKD. Circadian changes in phosphate were not explained by urine phosphate excretion, parathyroid hormone, or fibroblast growth factor-23. Conclusions: A circadian pattern of serum phosphate is observed in CKD with lowest concentrations at 0800 and highest at 1600 and 0400. This circadian pattern is modifiable by phosphate intake and most evident at 1600. Future intervention studies targeting intestinal phosphate absorption should consider afternoon phosphate measurements.

UR - http://www.scopus.com/inward/record.url?scp=84908125772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908125772&partnerID=8YFLogxK

U2 - 10.3945/ajcn.114.085498

DO - 10.3945/ajcn.114.085498

M3 - Article

VL - 100

SP - 1392

EP - 1397

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 5

ER -